Actively Recruiting
Study to Test Safety and Usability of New Intraocular Lens Designs for Adults Needing Cataract Surgery in Both Eyes
Led by Alcon Research · Updated on 2026-05-19
85
Participants Needed
4
Research Sites
26 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the safety and usability of a new intraocular lens IOL called AAL-FAIOL for adults who need cataract surgery in both eyes. The study is conducted in Central America and aims to compare the AAL-FAIOL lens with another lens called BAL-FAIOL. The goal is to explore how well these lenses work and how safe they are for long-term use after cataract removal. Participants will have cataract surgery in both eyes, with one eye receiving the AAL-FAIOL lens and the other eye receiving the BAL-FAIOL lens. The surgeries in the two eyes will be scheduled 14 to 35 days apart. The AAL-FAIOL lens can be adjusted after surgery using laser treatment if needed to improve vision. Both lenses are implanted during cataract surgery using a technique called phacoemulsification. During the study, participants will attend follow-up visits for about one year to monitor their eye health and vision. Researchers will check for any eye-related adverse events or complications, including any additional surgeries needed. The study will measure the overall safety of the lenses and how well participants do over this 12-month period after their surgeries.
CONDITIONS
Brief Title
Feasibility Study of an Accommodating IOL Design
Research Team
A
Alcon Call Center
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
